These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11860857)

  • 1. [Immunogenicity and long-term persistence of anti-HAV in groups with different attenuated and inactived hepatitis A vaccine dosage].
    Wang X; Ma J; Zhang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Apr; 22(2):111-3. PubMed ID: 11860857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary study on immunologic effect of live attenuated hepatitis A vaccine (H2 strain) after booster dose].
    Wang X; Ma J; Zhang Y; Zhang Y; Han C; Xing Z; Chen J; Zhang Y; Zhao S; Gu H; Xu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):124-7. PubMed ID: 11860772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
    Wang X; Meng Z; Li R
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study on safety and immunogenicity of an inactivated hepatitis A vaccine in HBsAg carriers and healthy children].
    Chen J; Ren Y; Wu W; Ma S; Li S; Wang J; Kang W; Han L; Gao S; Zhang Y; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):380-1. PubMed ID: 12665912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up.
    Wang XY; Xu ZY; Ma JC; von Seidlein L; Zhang Y; Hao ZY; Han OP; Zhang YL; Tian MY; Ouyang PY; Zhang ZY; Han CQ; Xing ZC; Chen JC
    Vaccine; 2007 Jan; 25(3):446-9. PubMed ID: 16949710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The investigation on the safety and immunogenicity of inactived hepatitis A vaccine AVAXIM].
    Huang G; Wan Z; Li R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):287-8. PubMed ID: 11860802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological effects of live attenuated hepatitis A vaccine (H(2)-strain): results of A 10-year observation].
    Zhuang F; Jiang Q; Gong Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):188-90. PubMed ID: 11860874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.
    Hammitt LL; Bulkow L; Hennessy TW; Zanis C; Snowball M; Williams JL; Bell BP; McMahon BJ
    J Infect Dis; 2008 Dec; 198(12):1776-82. PubMed ID: 18976095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.
    Ambrosch F; Finkel B; Herzog C; Koren A; Kollaritsch H
    Infection; 2004 Jun; 32(3):149-52. PubMed ID: 15188074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines.
    Wang XY; Xu Z; Yao X; Tian M; Zhou L; He L; Wen Y
    Vaccine; 2004 May; 22(15-16):1941-5. PubMed ID: 15121306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
    Van Herck K; Jacquet JM; Van Damme P
    J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
    D'Acremont V; Herzog C; Genton B
    J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Crasta P; Messier M; Jacquet JM; Van Herck K
    J Med Virol; 2012 Jan; 84(1):11-7. PubMed ID: 22052690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
    Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
    Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.